Cargando…
Selección de lo mejor de 2020 en riesgo vascular y rehabilitación cardiaca
2020 is the year of the COVID-19 pandemic when patients with cardiovascular disease or risk factors have had the highest morbidity and mortality. This is why cardiovascular prevention and cardiac rehabilitation are more essential than ever. The treatment with cardiovascular and renal protective drug...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Cardiología.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794048/ http://dx.doi.org/10.1016/j.rccl.2020.11.005 |
| Sumario: | 2020 is the year of the COVID-19 pandemic when patients with cardiovascular disease or risk factors have had the highest morbidity and mortality. This is why cardiovascular prevention and cardiac rehabilitation are more essential than ever. The treatment with cardiovascular and renal protective drugs in diabetes is unstoppable and has been updated in a new algorithm. Tobacco cessation, control of hypertension, dyslipidaemia, sedentary life and obesity are considered priorities. Also e-medicine has been implemented as never before in prevention and in order to reach the maximum number of patients, cardiac rehabilitation programs are no longer mostly face to face but online and e-supervised. The pandemic becomes an opportunity to boost prevention and cardiac rehabilitation, more necessary than ever and for everyone. |
|---|